Phoreus Biotechnology, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Olathe, Kansas. The company specializes in the development of proprietary nanocarriers for targeted drug delivery and enhanced treatments.
Subscribe to see Phoreus Biotechnology, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Phoreus Biotechnology, Inc. is a biotechnology company headquartered in Olathe, United States. Its most recent funding round raised $420,693 in November 2025. Xcout tracks 16 named people at Phoreus Biotechnology, Inc., including David Schaefer (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
10 more named people on record for Phoreus Biotechnology, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $420,693 | — | |
| SEC Form D filing | $4.4M | — | |
| SEC Form D filing | $50,000 | — | |
| — | $300,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Phoreus Biotechnology, Inc.'s closest competitors — see the full list of competitors and alternatives →
Day Three Labs Inc. is a biotechnology and pharmaceutical formulation company based in Denver, Colorado, founded in 2021. The company specializes in nanodelivery technologies that enhance the bioavailability of cannabinoid and pharmaceutical compounds.
Xanadu Bio, Inc. is a biotechnology company that develops next-generation polymer nanoparticle delivery platforms for mRNA and other nucleic acid-based therapies. Utilizing its proprietary poly(amine-co-ester) (PACE) polymer technology, the company creates tunable, organ-specific treatments for oncology and immunology, as well as intranasal vaccines for viral respiratory pathogens.
PhoreMost Ltd is a Cambridge, United Kingdom-based biotechnology and drug discovery company dedicated to turning scientific breakthroughs into life-changing cancer therapies.
Flashpoint Therapeutics is a clinical-stage biotechnology research company headquartered in Evanston, Illinois, developing a new class of precision-engineered structural nanomedicines through its proprietary platform.
pHLIP, Inc. is a privately held, clinical-stage biopharmaceutical company located in Kingston, Rhode Island, dedicated to improving patient outcomes using its proprietary pH-Low Insertion Peptide Platform.
NanoGhost is a biotechnology company that develops a targeted drug delivery platform using nanovesicles derived from the cell membranes of mesenchymal stem cells. The company serves the medical and pharmaceutical sectors by creating technologies designed to selectively target cancer and sites of inflammation for improved therapeutic delivery.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Phoreus Biotechnology, Inc.? Suggest a correction · Work at Phoreus Biotechnology, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.